169 related articles for article (PubMed ID: 34023214)
1. Role of pomegranate extract in restoring endometrial androgen receptor expression, proliferation, and pinopodes in a rat model of polycystic ovary syndrome.
Ibrahim MAA; Sadek MT; Sharaf Eldin HEM
Morphologie; 2022 Sep; 106(354):145-154. PubMed ID: 34023214
[TBL] [Abstract][Full Text] [Related]
2. Ficus deltoidea ameliorates biochemical, hormonal, and histomorphometric changes in letrozole-induced polycystic ovarian syndrome rats.
Haslan MA; Samsulrizal N; Hashim N; Zin NSNM; Shirazi FH; Goh YM
BMC Complement Med Ther; 2021 Nov; 21(1):291. PubMed ID: 34844580
[TBL] [Abstract][Full Text] [Related]
3. Effects of metformin on endocrine, metabolic milieus and endometrial expression of androgen receptor in patients with polycystic ovary syndrome.
Ito-Yamaguchi A; Suganuma R; Kumagami A; Hashimoto S; Yoshida-Komiya H; Fujimori K
Gynecol Endocrinol; 2015 Jan; 31(1):44-7. PubMed ID: 25237893
[TBL] [Abstract][Full Text] [Related]
4. Liuwei Dihuang Pills alleviate the polycystic ovary syndrome with improved insulin sensitivity through PI3K/Akt signaling pathway.
Qiu Z; Dong J; Xue C; Li X; Liu K; Liu B; Cheng J; Huang F
J Ethnopharmacol; 2020 Mar; 250():111965. PubMed ID: 31185267
[TBL] [Abstract][Full Text] [Related]
5. Investigation of the uterine structural changes in the experimental model with polycystic ovary syndrome and effects of vitamin D treatment: An ultrastructural and immunohistochemical study.
Kuyucu Y; Çelik LS; Kendirlinan Ö; Tap Ö; Mete UÖ
Reprod Biol; 2018 Mar; 18(1):53-59. PubMed ID: 29325695
[TBL] [Abstract][Full Text] [Related]
6. Ameliorative potential of rosmarinic acid in a rat model of polycystic ovary syndrome: Targeting MCP-1 and VEGF: A histological, immunohistochemical, and biochemical study.
Shalaby AM; Shalaby RH; Elshamy AM; Alnasser SM; Alorini M; Jaber FA; Alabiad MA; Alshaikh ABA; Hassan SMA; Aziz SAMA; Safa MA; Elkholy MR
Cell Biochem Funct; 2024 Jun; 42(4):e4073. PubMed ID: 38863227
[TBL] [Abstract][Full Text] [Related]
7. Serum anti-Müllerian hormone levels remain high until late reproductive age and decrease during metformin therapy in women with polycystic ovary syndrome.
Piltonen T; Morin-Papunen L; Koivunen R; Perheentupa A; Ruokonen A; Tapanainen JS
Hum Reprod; 2005 Jul; 20(7):1820-6. PubMed ID: 15802325
[TBL] [Abstract][Full Text] [Related]
8. Relevance of an opioid, noscapine in reducing cystogeneses in rat experimental model of polycystic ovary syndrome.
Priyadarshani A
J Endocrinol Invest; 2009 Nov; 32(10):837-43. PubMed ID: 19609106
[TBL] [Abstract][Full Text] [Related]
9. Tetragonia tetragonioides (Pall.) Kuntze Regulates Androgen Production in a Letrozole-Induced Polycystic Ovary Syndrome Model.
Pyun BJ; Yang H; Sohn E; Yu SY; Lee D; Jung DH; Ko BS; Lee HW
Molecules; 2018 May; 23(5):. PubMed ID: 29757997
[No Abstract] [Full Text] [Related]
10. Isorhamnetin inhibits inflammatory response to alleviate DHEA-induced polycystic ovary syndrome in rats.
Yu F; Xue Y; Zhao Y; Zhang L; He X; Liu Z
Gynecol Endocrinol; 2023 Dec; 39(1):2183045. PubMed ID: 36842967
[TBL] [Abstract][Full Text] [Related]
11. Ameliorative effects of fisetin in letrozole-induced rat model of polycystic ovary syndrome.
Mihanfar A; Nouri M; Roshangar L; Khadem-Ansari MH
J Steroid Biochem Mol Biol; 2021 Oct; 213():105954. PubMed ID: 34298098
[TBL] [Abstract][Full Text] [Related]
12. [Serum levels of anti-muller hormone in women with polycystic ovary syndrome and healthy women of reproductive age].
Parahuleva N; Pehlivanov B; Orbecova M; Deneva T; Uchikova E
Akush Ginekol (Sofiia); 2013; 52 Suppl 1():16-23. PubMed ID: 24294740
[TBL] [Abstract][Full Text] [Related]
13. Use of Bao Gui capsule in treatment of a polycystic ovary syndrome rat model.
Lian Y; Zhao F; Wang W
Mol Med Rep; 2020 Mar; 21(3):1461-1470. PubMed ID: 32016479
[TBL] [Abstract][Full Text] [Related]
14. Scaffold-Free Endometrial Organoids Respond to Excess Androgens Associated With Polycystic Ovarian Syndrome.
Wiwatpanit T; Murphy AR; Lu Z; Urbanek M; Burdette JE; Woodruff TK; Kim JJ
J Clin Endocrinol Metab; 2020 Mar; 105(3):769-80. PubMed ID: 31614364
[TBL] [Abstract][Full Text] [Related]
15. Increased uterine androgen receptor protein abundance results in implantation and mitochondrial defects in pregnant rats with hyperandrogenism and insulin resistance.
Zhang Y; Hu M; Yang F; Zhang Y; Ma S; Zhang D; Wang X; Sferruzzi-Perri AN; Wu X; Brännström M; Shao LR; Billig H
J Mol Med (Berl); 2021 Oct; 99(10):1427-1446. PubMed ID: 34180022
[TBL] [Abstract][Full Text] [Related]
16. Neuropeptide galanin and its effects on metabolic and reproductive disturbances in female rats with estradiol valerate (EV) - Induced polycystic ovary syndrome (PCOS).
Azin F; Khazali H
Neuropeptides; 2020 Apr; 80():102026. PubMed ID: 32063381
[TBL] [Abstract][Full Text] [Related]
17. L-Carnitine improves endocrine function and folliculogenesis by reducing inflammation, oxidative stress and apoptosis in mice following induction of polycystic ovary syndrome.
Kalhori Z; Mehranjani MS; Azadbakht M; Shariatzadeh MA
Reprod Fertil Dev; 2019 Jan; 31(2):282-293. PubMed ID: 31039949
[TBL] [Abstract][Full Text] [Related]
18. Effects of Electroacupuncture on Ovarian Expression of the Androgen Receptor and Connexin 43 in Rats with Letrozole-Induced Polycystic Ovaries.
Xu G; Zhang A; Liu J; Wang X; Feng J; Chen Y
Evid Based Complement Alternat Med; 2020; 2020():3608062. PubMed ID: 32733580
[TBL] [Abstract][Full Text] [Related]
19. Uterine anomalies in cell proliferation, energy homeostasis and oxidative stress in PCOS hamsters, M. auratus: Therapeutic potentials of melatonin.
Hansda SR; Haldar C
Life Sci; 2021 Sep; 281():119755. PubMed ID: 34175318
[TBL] [Abstract][Full Text] [Related]
20. Welsh Onion Root (
Lee YH; Yang H; Lee SR; Kwon SW; Hong EJ; Lee HW
Nutrients; 2018 Oct; 10(10):. PubMed ID: 30287740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
